Evogene Ltd. Share Price & Technical Analysis
EVGN · $0.70 (+1.45%)
Healthcare / Biotechnology
$0.70
+1.45%
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizin…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
-12% return in May, 3% avg return in past 3 year May month.
-43% return in 2026, -40% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -10% | -11% | 0% | -12% | – | – | – | – | – | – | – | -43% |
| 25 | -20% | 0% | -14% | -15% | 0% | 18% | -8% | 0% | -8% | 8% | -15% | 10% | -45% |
| 24 | -14% | 18% | -17% | -8% | 7% | -10% | -26% | -31% | -3% | -26% | -27% | 19% | -117% |
| 23 | 18% | -6% | -15% | -9% | 2% | 75% | -7% | -30% | -20% | -21% | 33% | 24% | 43% |
| 22 | -17% | -7% | 2% | -19% | -10% | -19% | 8% | 13% | -15% | -10% | -14% | 11% | -77% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$9.20M
P/E ratio
—
52W high
$2.42
52W low
$0.66
Volume
58,724
Beta
0.80
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Evogene Ltd. share price today?
- Evogene Ltd. (EVGN) last traded around $0.70 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does EVGN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for EVGN. Download the app for real-time alerts.
- How can I analyze Evogene Ltd. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.